Gamma glutamyltransferase and long-term survival: is it just the liver?

Lili Kazemi-Shirazi1, Georg Endler, Stefan Winkler

  • 1Institute of Medical and Chemical Laboratory Diagnostics, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.

Clinical Chemistry
|March 27, 2007
PubMed

Insights

Elevated gamma glutamyltransferase (GGT) levels are linked to increased all-cause mortality in both men and women, particularly in younger individuals. Even high-normal GGT indicates a significant risk for death.

Area of Science:

  • Biochemistry
  • Clinical Medicine
  • Epidemiology

Background:

  • Elevated gamma glutamyltransferase (GGT) is a known risk factor for cardiovascular disease.
  • Limited large-scale studies have explored the association between GGT and all-cause mortality.

Purpose of the Study:

  • To investigate the relationship between GGT levels and the risk of all-cause mortality.
  • To determine if GGT is a predictor of mortality across different age groups.

Main Methods:

  • A cohort study of 283,438 hospital patients with GGT analysis was conducted.
  • Patients were monitored for up to 13 years.
  • Cox proportional hazards models, adjusted for age and sex, were used to evaluate GGT as a predictor.

Main Results:

  • GGT levels above reference ranges were significantly associated with all-cause, cancer, hepatobiliary, and vascular mortality in both sexes (P <0.001).
  • Hazard ratios for mortality were similar between men and women.
  • Younger patients (<30 years) with elevated GGT exhibited higher all-cause mortality rates compared to older individuals.

Conclusions:

  • Gamma glutamyltransferase (GGT) is a significant predictor of mortality in both men and women.
  • Elevated GGT, even within high-normal ranges, is a risk factor for all-cause mortality.
  • The association between GGT and mortality is particularly pronounced in younger individuals (<30 years).
Abstract

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...